the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Subahan: ‘Reward’ awaits national men’s five-a-side hockey team

KUALA LUMPUR: The national five-a-side men’s hockey team are in for a “windfall” after making history by qualifying for the final of the inaugural Hockey5s World Cup 2024 in Muscat, Oman.

Malaysian Hockey Confederation (MHC) president Datuk Seri Subahan Kamal (pix) said they have considered the matter despite currently facing financial constraints.

“I will make sure they get the reward when they get home. I sympathise with them because we (MHC) are also financially tied… we’ve spent a lot for the national team.

“I daren’t even mention their training allowance. Sometimes, they ask for new shoes and we can’t even afford them, but they never demand (for anything),” he told a media conference at the MHC in Bukit Jalil here today.

Subahan said even the team coach, Wallace Tan, who has guided his charges to such an encouraging result in Oman, declined to be paid a salary.

“He did that because he wanted to help us (MHC), but we do give them allowances, though,” he said.

Earlier today, the national five-a-side team edged Poland 4-3 in the semi-finals to set up a title showdown against the Netherlands tonight.

Following the inspiring performances of both the men’s and women’s five-a-side teams at the Hockey5s World Cup, Subahan said the MHC will try to convince the Youth and Sports Ministry to create full-time programmes involving the two squads as well as the national indoor hockey teams.

This, he said, is aimed at preparing the five-a-side and indoor hockey teams for various upcoming tournaments. -Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings